Oshrat Harush-Frenkel

Author

Also Known As

Oshrat Harush-Frenkel

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Oshrat Harush-Frenkel is an author at Hebrew University of Jerusalem specializing in nanomedicine, nanoparticles, and engineering.

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	1.1K
2	Medicine	3	3	460
3	Biomedical Engineering	2	2	485
4	Cell Biology	2	2	948
5	Cellular Physiology	1	1	401

Oshrat Harush-Frenkel

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Targeting of nanoparticles to the clathrin-mediated endocytic pathway Oshrat Harush-Frenkel, Nir Debotton, Simon Benita, Biochemical and Biophysical Research Communications NanoparticlesNanomedicineDrug TargetingEngineeringClathrin-mediated Endocytic Pathway	2006	547
Surface Charge of Nanoparticles Determines Their Endocytic and Transcytotic Pathway in Polarized MDCK Cells Oshrat Harush-Frenkel, Eva Rozentur, Simon Benita, Biomacromolecules NanoparticlesEngineeringBiomedical EngineeringCellular PhysiologyPolarized Mdck Cells	2008	401
A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery Oshrat Harush-Frenkel, Maytal Bivas‐Benita, Taher Nassar, Toxicology and Applied Pharmacology NanoparticlesNanomedicineEngineeringNanomaterialsPharmaceutical Nanotechnology	2010	84
High Plasma Levels and Effective Lymphatic Uptake of Docetaxel in an Orally Available Nanotransporter Formulation Taher Nassar, Suha Attili-Qadri, Oshrat Harush-Frenkel, Cancer Research NanomedicinePharmaceutical ScienceDocetaxel ChemotherapyPolymer-drug ConjugateEffective Lymphatic Uptake	2011	35
A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance Nir Debotton, Hagit Zer, Marcela Parnes, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineImmunocytochemical TechniqueEngineeringProtein Nanoparticles	2009	24

Page 1